Acute Leukoencephalopathies:Differential Diagnosis and Investigation
The Neurologist 4:148-166, Weinshenker,B.G.,et al, 1998
The Spectrum of Neurol Dis Assoc with Antiphospholipid Antibd, Lupus Anticoag & Anticardiolipin Antibd
Arch Neurol 44:876-883, Levin,S.R.&Welch,K.M.A., 1987
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
New Treatments for Migraine: CGRP Monoclonal Antibodies, Gepants, and Ditans
BMJ 390:e085564, Burch, R. & Rittenberg, E., 2025
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024
Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019
Preventive Migraine Drug Approved
JAMA 320:1746, , 2018
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018
Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018
Clinicopathologic Conference, MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke like episodes)
NEJM 376:1668-1678, CASE 13-2017, 2017
CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017
Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Neurol 86:1818-1826, Simpson, D.M.,et al, 2016
Acute Headache Diagnosis in Pregnant Women
Neurol 85:1024-1030, Robbins, M.S.,et al, 2015
Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults
JAMA 307:1736-1745, Jackson,J.L.,et al, 2012
Tricyclic Antidepressants and Headaches: Systematic Review and Meta-Analysis
BMJ 341:c5222, Jackson,J.L.,et al, 2010
Migraine and Cardiovascular Disease: Systematic Review and Meta-Analysis
BMJ 339:b3914, Sch�rks,M.,et al, 2009
Botulinum Toxin Type A for the Treatment of Headache: Why We Say Yes
Arch Neurol 65:146-149,151, Ashkenazi,A. &Silberstein,S., 2008
Headache Therapy With Botulinum Toxin: Form Over Substance
Arch Neurol 65:149-151,151, Pakalnis,A. &Couch,J., 2008
Headache and Pregnancy
The Neurologist 14:108-119, Menon,R. &Bushnell,C.D., 2008
Migrainous Corpalgia: Body Pain and Allodynia Associated with Migraine Attacks
Cephalagia 28:87-91, Cuadrado,M.L.,et al, 2007
Postpartum Headache: Is Your Work-Up Complete?
Am J Obstet Gynecol 196:318.e1-318.e7, Stella,C.L.,et al, 2007
Primary Episodic Ataxias:Diagnosis, Pathogenesis and Treatment
Brain 130:2484-2493, Jen, J.C.,et al, 2007
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
Migraine and Risk of Cardiovascular Disease in Women
JAMA 296:283-291,333, Kurth,T.,et al, 2006
Mitochondrial DNA Polymerase-y and Human Disease
Hum Mol Genet 15:R244-R252, Hudson, G.,et al, 2006
Ability of a Nurse Specialist to Diagnose Simple Headache Disorders Compared with Consultant Neurologists
JNNP 76:1170-1172, Clarke,C.E.,et al, 2005
Trpitans in Migraine
Neurol 62:563-568, Hall,G.C.,et al, 2004
Association Between Migraine and Celiac Disease: Results From a Preliminary Case-Control and Therapeutic Study
, Gabrielli, M.,et al, 2003
Headache Diagnosis in Patients with Treated Idiopathic Intracranial Hypertension
Neurol 58:1551-1553, Friedman,D.I. &Rausch,E.A., 2002
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Int Med 159:511-513, Liston,H.,et al, 1999
Ion Channel Diseases:Episodic Disorders of the Nervous System
Semin Neurol 19:363-369, Ptacek,L.J., 1999
Role of Anticardiolipin Antibodies in Young Persons with Migraine & Trans Focal Neuro Events, Prospect Study
Neurol 50:1433-1440, Tietjen,G.E.,et al, 1998
Neurological Channelopathies, Dysfunctional Ion Channels May Cause Many Neurological Diseases
BMJ 316:1104-1105, Rose,M.R., 1998
Ion Channels and Neurological Disease:DNA Based Diagnosis is Now Possible,and Ion Channels May be Important in Common Paroxysmal Disorders
JNNP 65:427-431, Hanna,M.G.,et al, 1998
Botulinum Toxin A,AdjunctiveTherapy for Refractory Headaches Associated with Pericranial Muscle Tension
Headache 38:468-471, Wheeler,A.H., 1998
The Natural Course of Cerebral Lesions in Sneddon Syndrome
Arch Neurol 54:53-60, Tourbah,A.,et al, 1997
Autonomic Ganglionitis with Severe Hypertension, Migraine, and Episodic but Fatal Hypotension
Neurol 47:817-821, Lee,H.C.,et al, 1996
Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996
Classification of Daily and Near-Daily Headaches:Field Trial of Revised IHS Criteria
Neurol 47:871-875, Silberstein,S.D.,et al, 1996
Familial Hemiplegic Migraine and Autosomal Dominant Arteriopathy with Leukoencephalopathy (CADASIL)
Ann Neurol 38:817-824, Hutchinson,M.,et al, 1995
Headache
JNNP 57:134-143, Pearce,J.M.S., 1994